Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07140640 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 26, 2026 (before its estimated September 15, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 6 months later Mar 15, 2026 → Sep 15, 2026
Primary endpoint removed 2 → 1 primary endpoints
See other at-risk trials from Aswan University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Mar 15, 2026 to Sep 15, 2026v2 Show 9 more changesShow less
    • Primary endpoint(s) modified
    • Recruitment opened
    • Enrollment increased: 333 → 666 participants
    • Study completion pushed from Mar 30, 2026 to Sep 30, 2026
    • Secondary endpoints expanded, about 12 words
    • Study description expanded, about 307 words
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    • Study title shortened, about 5 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Trial Details
NCT Number NCT07140640
Lead Sponsor Aswan University
Conditions
(from sponsor)		 Cesarean Section Complications
Enrollment 666 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov